top of page
Search

Leukaemias for MRCP Part 1: AML, ALL, CML & CLL — The Ultimate List

TL;DR:

 This clinician-written guide distils the four core leukaemias tested in MRCP Part 1—AML, ALL, CML and CLL—into recognition patterns, must-know genetics, and exam traps. You’ll get a high-yield outline, a short MCQ with explanation, and a practical study checklist to convert revision time into marks.


Why this topic matters for MRCP Part 1

Leukaemia questions are reliable scorers because they test pattern recognition rather than treatment minutiae. Candidates who can rapidly match age, blood film clues, and signature cytogenetics to a diagnosis outperform those who memorise protocols. This post supports the core haematology hub on the MRCP Part 1 overview and points you to focused practice via Free MRCP MCQs and timed assessment with Start a mock test.


Scope & exam blueprint (what the examiners actually test)

Expect stems that ask you to:

  • Classify acute vs chronic and myeloid vs lymphoid disease

  • Use age + presentation to narrow the diagnosis

  • Recognise blood film hallmarks

  • Recall high-yield cytogenetics

  • Choose first-line principles (not full regimens)

The Ultimate List (high-yield outline)

1) Acute Myeloid Leukaemia (AML)

  • Who: Typically adults

  • Clues: Fatigue, infections, bleeding; Auer rods on film

  • Genetics to know: t(15;17) → acute promyelocytic leukaemia (APL)

  • Exam pearl: APL carries a high risk of DIC → start ATRA immediately

  • Trap: Mistaking APL-related bleeding for ITP

2) Acute Lymphoblastic Leukaemia (ALL)

  • Who: Common in children; also tested in adults

  • Clues: Bone pain, lymphadenopathy; mediastinal mass (T-cell)

  • Genetics: t(12;21) favourable in children; Philadelphia chromosome may occur in adults

  • Markers: TdT positive

  • Trap: Forgetting CNS involvement as a testing concept

3) Chronic Myeloid Leukaemia (CML)

  • Who: Middle-aged adults

  • Clues: Marked leukocytosis, basophilia, splenomegaly

  • Genetics: BCR-ABL (Philadelphia chromosome)

  • Principle: Treat with tyrosine kinase inhibitors

  • Trap: Calling a leukemoid reaction CML (LAP score helps)

4) Chronic Lymphocytic Leukaemia (CLL)

  • Who: Older adults (>60 years)

  • Clues: Incidental lymphocytosis, infections, autoimmune cytopenias

  • Blood film: Smudge cells

  • Markers: CD5+, CD19+, CD23+

  • Trap: Treating early asymptomatic disease—watchful waiting is standard


One-page comparison table (exam memory aid)

Feature

AML

ALL

CML

CLL

Onset

Acute

Acute

Chronic

Chronic

Typical age

Adults

Children/young

Middle-aged

Elderly

Key clue

Auer rods

TdT+, mediastinal mass

Basophilia

Smudge cells

Signature genetics

t(15;17)

t(12;21)

BCR-ABL

del(13q) common

First-line principle

ATRA in APL

Combination chemo

TKI

Observe if early

The 5 most tested subtopics

  1. APL & DIC: ATRA is urgent—don’t delay

  2. Philadelphia chromosome: Central to CML; present in some adult ALL

  3. Basophilia: Strong pointer to CML

  4. Smudge cells: Classic for CLL

  5. Observation strategy: Appropriate in early CLL


Practical example (mini-MCQ)

Stem: A 29-year-old presents with bruising and gum bleeding. FBC shows anaemia and thrombocytopenia with circulating blasts. Blood film demonstrates Auer rods. Coagulation profile suggests DIC.

Question: What is the most important immediate management step?

Answer: Start all-trans retinoic acid (ATRA).Explanation: This is APL (AML with t(15;17)). Early ATRA rapidly reduces life-threatening haemorrhage from DIC—this action is repeatedly tested in MRCP Part 1.


MRCP Part 1 haematology study setup focusing on leukaemias

Common pitfalls (5 you should actively avoid)

  • Confusing leukemoid reaction with CML

  • Missing APL and failing to prioritise ATRA

  • Treating asymptomatic CLL unnecessarily

  • Ignoring age patterns

  • Over-learning regimens instead of recognition cues


Practical study-tip checklist

  • Anchor each leukaemia to age + one defining clue

  • Memorise three genetics: t(15;17), t(12;21), BCR-ABL

  • Review blood films daily (Auer rods, smudge cells)

  • Practise mixed blocks on Free MRCP MCQs

  • Benchmark progress with Start a mock test

  • Use concise Haematology lectures for consolidation


FAQs

Is leukaemia classification heavily tested in MRCP Part 1?

Yes. The exam rewards rapid classification using age, film clues and genetics.

Do I need to memorise chemotherapy regimens?

No. Focus on first-line principles and red-flag actions (e.g. ATRA in APL).

How do I differentiate CML from a leukemoid reaction?

Basophilia and a low LAP score favour CML; clinical context matters.

Is CLL always treated immediately?

No. Early, asymptomatic CLL is managed with observation.


Ready to start?

Turn this framework into marks: practise targeted questions on Free MRCP MCQs and test readiness with a timed paper via Start a mock test from the MRCP Part 1 hub.


Sources

 
 
 

Comments

bottom of page